SOX11 and ovarian serous adenocarcinoma: In this regard, the results of our study indicate, for the first time, SOX11 overexpression as a possible factor that could interfere in the promotion of EMT in serous ovarian cancer, hence being involved in the mechanism’s underlying tumor metastasis.